Vasina V.; Broccoli M.; Ursino M.G.; Bellot S.F.; Soleti A.; Paolini M.; De Ponti F., Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats., «EUROPEAN JOURNAL OF PHARMACOLOGY», 2009, 614, pp. 137 - 145 [Scientific article]
Raschi E; Poluzzi E; Zuliani C; Muller A; Goossens H; De Ponti F., Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period., «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2009, 67, pp. 88 - 98 [Scientific article]
Raschi E.; Ceccarini L.; De Ponti F.; Recanatini M., hERG-related drug toxicity and models for predicting hERG liability and QT prolongation, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2009, 5, pp. 1005 - 1021 [Scientific article]
Ursino M.G.; Vasina V.; De Ponti F., Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats, «EUROPEAN JOURNAL OF PHARMACOLOGY», 2009, 603, pp. 133 - 137 [Scientific article]
Sinagra G.; Patrono C.; De Ponti F., Reazioni avverse cardiovascolari, in: Reazioni avverse a farmaci: sospetto e diagnosi, MILANO, Cortina, 2009, pp. 65 - 90 [Chapter or essay]
Pagliaro L.; De Ponti F., Reazioni avverse epatiche, in: Reazioni avverse a farmaci: sospetto e diagnosi, MILANO, Cortina, 2009, pp. 143 - 162 [Chapter or essay]
Ursino M.G.; Vasina V.; Raschi E.; Crema F.; De Ponti F., The beta3-adrenoceptor as a therapeutic target: current perspectives., «PHARMACOLOGICAL RESEARCH», 2009, 59, pp. 221 - 234 [Scientific article]
E. Poluzzi; E. Raschi; C. Zuliani; A. Muller; H. Goossens; F. De Ponti, Exposure to antibacterials with QT-liability in 15 European countries: trends over a 7-year period., in: Supplement: Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Copenhagen, Denmark, August 17–20, 2008., «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2008, 17, pp. S1 - S294. (atti di: 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Copenaghen, August 17-20) [Abstract]
Memo M.; De Ponti F.; Eandi M. (a cura di): AUTORI VARI, Farmacologia generale e applicata, BOLOGNA, Monduzzi, 2008, pp. 319 . [Editorship]
De Ponti F., Pharmacological and Regulatory Aspects of QT Prolongation, in: Antitargets, WEINHEIM, WILEY-VCH Verlag, 2008, pp. 55 - 88 [Chapter or essay]
De Ponti F., Principi e metodi per la somministrazione di medicinali, in: AUTORI VARI, Farmacologia generale e applicata, BOLOGNA, Monduzzi, 2008, pp. 161 - 185 [Chapter or essay]
Drago A; De Ponti F; Boriani G; De Ronchi D; Serretti A., Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia., «CURRENT MEDICINAL CHEMISTRY», 2008, 15(24), pp. 2472 - 2517 [Scientific article]
Vasina V; Abu-Gharbieh E; Barbara G; de Giorgio R; Colucci R; Blandizzi C; Bernardini N; Croci T; Del Tacca M; de Ponti F., The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats., «NEUROGASTROENTEROLOGY AND MOTILITY», 2008, 20 (9), pp. 1030 - 1041 [Scientific article]
Raschi E; Vasina V; Poluzzi E; De Ponti F., The hERG K+ channel: target and antitarget strategies in drug development., «PHARMACOLOGICAL RESEARCH», 2008, 57, pp. 181 - 195 [Scientific article]
Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Ponti F.; Montanaro N., Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2007, 63, pp. 346 - 355 [Scientific article]
